-+ 0.00%
-+ 0.00%
-+ 0.00%

Sight Sciences Q1 net loss narrows to $13 million; revenue rises 13% to $19.7 million

PUBT·05/06/2026 20:18:56
Listen to the news
Sight Sciences Q1 net loss narrows to $13 million; revenue rises 13% to $19.7 million
  • Sight Sciences posted Q1 revenue of USD 19.7 million, up 13% year over year, as Interventional Dry Eye revenue more than tripled to USD 1.4 million.
  • Net loss narrowed to USD 13 million, or USD 0.24 per share, while gross margin was unchanged at 86%.
  • Operating expenses rose 2% to USD 29.4 million, including a one-time USD 5.4 million success fee tied to the final judgment in Alcon litigation.
  • Cash used was USD 7 million, improving 40% year over year, with cash and cash equivalents of USD 85 million at March 31.
  • Full-year revenue guidance was raised to USD 83 million-USD 89 million from USD 82 million-USD 88 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sight Sciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605061605PRIMZONEFULLFEED9714653) on May 06, 2026, and is solely responsible for the information contained therein.